Europe Circulating Tumor Cell Market Size, Share & Trends Analysis Report By Product, By End User, Based on Specimen, By Technology, By Application (Research, Clinical, and Drug/Therapy Development), By Country and Growth Forecast, 2024 - 2031

Europe Circulating Tumor Cell Market Size, Share & Trends Analysis Report By Product, By End User, Based on Specimen, By Technology, By Application (Research, Clinical, and Drug/Therapy Development), By Country and Growth Forecast, 2024 - 2031

The Europe Circulating Tumor Cell Market would witness market growth of 13.0% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Circulating Tumour Cell Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,842.2 million by 2031. UK market is exhibiting a CAGR of 12.1% during (2024 - 2031). Additionally, The France market would experience a CAGR of 13.9% during (2024 - 2031).

The adoption of CTC-based technologies has grown significantly over the past few years, driven by advances in liquid biopsy techniques, an increasing understanding of cancer biology, and a rising demand for less invasive diagnostic methods. Significant breakthroughs in CTC isolation and detection technologies, such as microfluidics, immunomagnetic capture, and imaging techniques, have enabled the accurate and efficient collection of CTCs from blood samples.

Moreover, innovations in molecular analysis, such as next-generation sequencing (NGS) and single-cell RNA sequencing, have further enhanced the ability to profile CTCs and gain insights into their genetic makeup.

The rising incidence of prostate and bladder cancer in Europe is driving a growing demand for advanced diagnostic and monitoring solutions, such as circulating tumor cell technologies. With prostate cancer being the most common cancer among men and bladder cancer ranking fifth in terms of prevalence, there is an urgent need for effective early detection and non-invasive diagnostic methods.

Based on Product, the market is segmented into Kits & Reagents, Devices, and Blood Collection Tubes. Based on End User, the market is segmented into Research and Academic Institutes, Hospital & Clinics, and Diagnostic Centers. Based on Specimen, the market is segmented into Blood, Bone Marrow, and Other Specimen. Based on Technology, the market is segmented into CTC Detection & Enrichment Methods, CTC Analysis, and CTC Direct Detection. Based on Application, the market is segmented into Research, Clinical, and Drug/Therapy Development. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• Qiagen N.V
• Greiner Bio-One International GmbH
• Sysmex Corporation
• Miltenyi Biotech B.V & Co kg
• Bio-Techne Corporation
• Ikonisys, Inc.
• Menarini Silicon Biosystems SpA
• LungLife AI Inc.
• Aviva Systems Biology Corporation
• ScreenCell

Europe Circulating Tumor Cell Market Report Segmentation

By Product

• Kits & Reagents
• Devices
• Blood Collection Tubes

By End User

• Research and Academic Institutes
• Hospital & Clinics
• Diagnostic Centers

By Specimen

• Blood
• Bone Marrow
• Other Specimen

By Technology

• CTC Detection & Enrichment Methods
• CTC Analysis
• CTC Direct Detection

By Application

• Research, Clinical
• Drug/Therapy Development

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe